Company profile for Bolt Biotherapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bolt Biotherapeutics is a vibrant biotechnology company actively developing its novel Boltbody™ platform, a cancer immunotherapy that consists of Immune-Simulating Antibody Conjugates (ISAC). Located in the San Francisco Bay Area, Bolt is led by a team with extensive oncology drug development experience and is seeking bright, self-motivated individuals who share their passion for bringing novel and curative biotherapies to p...
Bolt Biotherapeutics is a vibrant biotechnology company actively developing its novel Boltbody™ platform, a cancer immunotherapy that consists of Immune-Simulating Antibody Conjugates (ISAC). Located in the San Francisco Bay Area, Bolt is led by a team with extensive oncology drug development experience and is seeking bright, self-motivated individuals who share their passion for bringing novel and curative biotherapies to patients in need

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
640 Galveston Drive Redwood City, CA 94063
Telephone
Telephone
650.665.9295
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/12/3186772/0/en/Bolt-Biotherapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/10/01/3159924/0/en/Bolt-Biotherapeutics-Provides-Update-on-BDC-4182-and-Extends-Cash-Runway-into-2027.html

GLOBENEWSWIRE
01 Oct 2025

https://www.globenewswire.com/news-release/2025/08/14/3133839/0/en/Bolt-Biotherapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
14 Aug 2025

https://www.globenewswire.com/news-release/2025/05/12/3079551/0/en/Bolt-Biotherapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
12 May 2025

https://www.globenewswire.com/news-release/2025/05/08/3077202/0/en/Bolt-Biotherapeutics-to-Host-KOL-Conference-Call-and-Webcast-to-Discuss-BDC-3042-Phase-1-Results-and-Corporate-Updates.html

GLOBENEWSWIRE
08 May 2025

https://www.globenewswire.com/news-release/2025/04/30/3071841/0/en/Bolt-Biotherapeutics-Presents-Preclinical-Results-for-Next-Generation-Boltbody-ISACs-targeting-CEA-and-PD-L1-at-AACR-Annual-Meeting-2025.html

GLOBENEWSWIRE
30 Apr 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty